<b>Conclusions:</b> These results highlight the importance of early detection of GAD65 antibodies in refractory epilepsy as immunotherapy can be effective if administered in the early stages of the disease when it can prevent permanent brain tissue damage. This evidence concerns the gene GAD2 and epilepsy.